ZIMBERELIMAB
UNII ZBL7O904IL

Substance Identification & Data

This profile provides standardized clinical and technical data for Zimberelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZBL7O904IL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2259860-24-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZBL7O904IL

CAS Registry Number

2259860-24-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZIMBERELIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C159549

National Cancer Institute reference terminology for clinical and research data.

INN ID

11413

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-142

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zimberelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZIMBERELIMAB

Common Names & Synonyms

ANTI-PD-1 MONOCLONAL ANTIBODY GLS-010

IMMUNOGLOBULIN G4(231-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL AB122 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AB122 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-LAMBDA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (HPD-1, CD279-ANTIGEN)); HOMO SAPIENS MONOCLONAL ANTIBODY; .GAMMA.4 HEAVY CHAIN HOMO SAPIENS (1-450) (VH (HOMO SAPIENS IGHV4-39*01 (88%) (IGHD)-IGHJ4*01) (10.7.15) (1-123)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(231))) (124-450)) (137-215')-DISULFIDE WITH .LAMBDA. LIGHT CHAIN HOMO SAPIENS (1'-216') (V-LAMBDA (HOMO SAPIENS IGLV2-14*03 (96%) IGLJ3*02)(9.3.10) (1'-110')-HOMO SAPIENS IGLC2*01 (111'-216')), DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHO-K1 CELL LINE, GLYCOFORM ALFA. POST-TRANSLATIONAL MODIFICATIONS: K(450) AND K(450'') DELETED, N(300) AND N(300'') GLYCOSYLATED

ZIMBERELIMAB [INN]

ZIMBERELIMAB [USAN]

ZIMBERELIMAB [WHO-DD]